TherapeuticsMD, Inc. (TXMD)

TherapeuticsMD Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	4.33	49.32	64.91	80.49	160.83
Cash & Cash Equivalents	4.33	49.32	64.91	80.49	160.83
Cash Growth	-91.23%	-24.02%	-19.36%	-49.96%	-0.48%
Receivables	3.09	0	0	32.38	24.4
Inventory	0	0	0	7.99	11.86
Other Current Assets	4.38	6.03	54.56	7.54	11.33
Total Current Assets	11.8	55.35	119.47	128.4	208.42
Property, Plant & Equipment	6.87	7.66	9.06	11.51	12.62
Goodwill and Intangibles	6.1	6.94	7.14	41.45	44.48
Other Long-Term Assets	18.54	20.51	33.8	0.25	0.47
Total Long-Term Assets	31.51	35.11	50	53.21	57.57
Total Assets	43.31	90.46	169.47	181.61	265.99
Accounts Payable	0.03	2.16	3.37	21.07	19.18
Current Debt	0	0	188.27	0	0
Other Current Liabilities	6.83	44.68	61.25	38.17	33.82
Total Current Liabilities	6.85	46.84	252.89	59.24	53
Long-Term Debt	6.53	7.37	8.06	246.37	203.78
Other Long-Term Liabilities	0.64	1.11	2.14	0	0
Total Long-Term Liabilities	7.17	8.48	10.2	246.37	203.78
Total Liabilities	14.02	55.32	263.09	305.61	256.78
Total Debt	6.53	7.37	196.33	246.37	203.78
Debt Growth	-11.36%	-96.25%	-20.31%	20.90%	177.70%
Retained Earnings	-949.64	-939.36	-1,051.36	-878.95	-695.42
Shareholders' Equity	29.29	35.14	-93.62	-124	9.2
Net Cash / Debt	-2.21	41.95	-131.43	-165.89	-42.95
Net Cash Per Share	-0.21	4.48	-16.51	-30.09	-8.72
Working Capital	4.94	8.51	-133.42	69.17	155.41
Book Value Per Share	2.81	3.89	-11.76	-22.49	1.87

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).